A citation-based method for searching scientific literature


List of co-cited articles
27 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis.
John D Pauling, Robyn T Domsic, Lesley A Saketkoo, Celia Almeida, Jane Withey, Hilary Jay, Tracy M Frech, Francesca Ingegnoli, Emma Dures, Joanna Robson,[...]. Arthritis Care Res (Hoboken) 2018
36
60


Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Randomized, Placebo-Controlled, Phase II Study.
Christopher P Denton, Éric Hachulla, Gabriela Riemekasten, Andreas Schwarting, Jean-Marie Frenoux, Aline Frey, Franck-Olivier Le Brun, Ariane L Herrick. Arthritis Rheumatol 2017
34
60

Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
Peter A Merkel, Karen Herlyn, Richard W Martin, Jennifer J Anderson, Maureen D Mayes, Patrice Bell, Joseph H Korn, Robert W Simms, Mary Ellen Csuka, Thomas A Medsger,[...]. Arthritis Rheum 2002
231
60

A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography: Outcome Measures for Systemic Sclerosis-Related Raynaud's Phenomenon.
Jack D Wilkinson, Sarah A Leggett, Elizabeth J Marjanovic, Tonia L Moore, John Allen, Marina E Anderson, Jason Britton, Maya H Buch, Francesco Del Galdo, Christopher P Denton,[...]. Arthritis Rheumatol 2018
37
60

Seasonal variation of Raynaud's phenomenon secondary to systemic sclerosis.
H R Watson, R Robb, G Belcher, J J Belch. J Rheumatol 1999
29
60

BSR and BHPR guideline for the treatment of systemic sclerosis.
Christopher P Denton, Michael Hughes, Nataliya Gak, Josephine Vila, Maya H Buch, Kuntal Chakravarty, Kim Fligelstone, Luke L Gompels, Bridget Griffiths, Ariane L Herrick,[...]. Rheumatology (Oxford) 2016
77
60

Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis.
Michael Hughes, Voon H Ong, Marina E Anderson, Frances Hall, Pia Moinzadeh, Bridget Griffiths, Eileen Baildam, Christopher P Denton, Ariane L Herrick. Rheumatology (Oxford) 2015
72
60

Factors Influencing Raynaud Condition Score Diary Outcomes in Systemic Sclerosis.
John D Pauling, Elizabeth Reilly, Theresa Smith, Tracy M Frech. J Rheumatol 2019
14
60

The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Ricardo J Bello, Carisa M Cooney, Eitan Melamed, Keith Follmar, Gayane Yenokyan, Gwendolyn Leatherman, Ami A Shah, Fredrick M Wigley, Laura K Hummers, Scott D Lifchez. Arthritis Rheumatol 2017
49
60

Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey.
Marielle Bassel, Marie Hudson, Suzanne S Taillefer, Orit Schieir, Murray Baron, Brett D Thombs. Rheumatology (Oxford) 2011
133
40

Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
F M Wigley, J H Korn, M E Csuka, T A Medsger, N F Rothfield, M Ellman, R Martin, D H Collier, A Weinstein, D E Furst,[...]. Arthritis Rheum 1998
117
40


Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group Report.
John D Pauling, Tracy M Frech, Michael Hughes, Jessica K Gordon, Robyn T Domsic, Marina E Anderson, Francesca Ingegnoli, Neil J McHugh, Sindhu R Johnson, Marie Hudson,[...]. J Scleroderma Relat Disord 2018
22
40

Evaluation of test characteristics for outcome measures used in Raynaud's phenomenon clinical trials.
Heather Gladue, Paul Maranian, Harold E Paulus, Dinesh Khanna. Arthritis Care Res (Hoboken) 2013
24
40

The patient experience of Raynaud's phenomenon in systemic sclerosis.
John D Pauling, Lesley Ann Saketkoo, Marco Matucci-Cerinic, Francesca Ingegnoli, Dinesh Khanna. Rheumatology (Oxford) 2019
24
40

Prediction and impact of attacks of Raynaud's phenomenon, as judged by patient perception.
Michael Hughes, Amir Snapir, Jack Wilkinson, Daniel Snapir, Fredrick M Wigley, Ariane L Herrick. Rheumatology (Oxford) 2015
33
40


Raynaud's phenomenon and its impact on activities in daily life during one year of follow-up in early systemic sclerosis.
G Sandqvist, P Wollmer, A Scheja, M Wildt, R Hesselstrand. Scand J Rheumatol 2018
4
50

Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials.
Matthieu Roustit, Sophie Blaise, Yannick Allanore, Patrick H Carpentier, Evren Caglayan, Jean-Luc Cracowski. Ann Rheum Dis 2013
88
40

Treatment Algorithms for Systemic Sclerosis According to Experts.
Andreu Fernández-Codina, Kyle M Walker, Janet E Pope. Arthritis Rheumatol 2018
101
40

Calcium channel blockers for primary and secondary Raynaud's phenomenon.
Fadumo Rirash, Paul C Tingey, Sarah E Harding, Lara J Maxwell, Elizabeth Tanjong Ghogomu, George A Wells, Peter Tugwell, Janet Pope. Cochrane Database Syst Rev 2017
24
40

Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
B Coleiro, S E Marshall, C P Denton, K Howell, A Blann, K I Welsh, C M Black. Rheumatology (Oxford) 2001
143
40


Update of EULAR recommendations for the treatment of systemic sclerosis.
Otylia Kowal-Bielecka, Jaap Fransen, Jerome Avouac, Mike Becker, Agnieszka Kulak, Yannick Allanore, Oliver Distler, Philip Clements, Maurizio Cutolo, Laszlo Czirjak,[...]. Ann Rheum Dis 2017
473
40




The efficacy of resiliency training programs: a systematic review and meta-analysis of randomized trials.
Aaron L Leppin, Pavithra R Bora, Jon C Tilburt, Michael R Gionfriddo, Claudia Zeballos-Palacios, Megan M Dulohery, Amit Sood, Patricia J Erwin, Juan Pablo Brito, Kasey R Boehmer,[...]. PLoS One 2014
140
20

Raynaud's Phenomenon.
Fredrick M Wigley, Nicholas A Flavahan. N Engl J Med 2016
121
20

An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups.
Murray Baron, Bashar Kahaleh, Elana J Bernstein, Lorinda Chung, Philip J Clements, Christopher Denton, Robyn T Domsic, Nava Ferdowsi, Ivan Foeldvari, Tracy Frech,[...]. J Scleroderma Relat Disord 2019
8
20

Development of a provisional core set of response measures for clinical trials of systemic sclerosis.
D Khanna, D J Lovell, E Giannini, P J Clements, P A Merkel, J R Seibold, M Matucci-Cerinic, C P Denton, M D Mayes, V D Steen,[...]. Ann Rheum Dis 2008
61
20

One- and two-item measures of pain beliefs and coping strategies.
Mark P Jensen, Francis J Keefe, John C Lefebvre, Joan M Romano, Judith A Turner. Pain 2003
196
20

Effects of coping statements on experimental pain in chronic pain patients.
Daniela Roditi, Michael E Robinson, Nola Litwins. J Pain Res 2009
14
20

Pain coping strategies predict perceived control over pain.
Jennifer A Haythornthwaite, Lynette A Menefee, Leslie J Heinberg, Michael R Clark. Pain 1998
86
20

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron, Alan Tyndall, Marco Matucci-Cerinic, Raymond P Naden, Thomas A Medsger, Patricia E Carreira,[...]. Arthritis Rheum 2013
20

Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis.
Ariane L Herrick, Frank van den Hoogen, Armando Gabrielli, Nihad Tamimi, Carol Reid, Damian O'Connell, Maria-Dolores Vázquez-Abad, Christopher P Denton. Arthritis Rheum 2011
68
20


Seasonal variations of Google searches for joint swelling: implications for patient-reported outcomes.
Sizheng Zhao, Stephen J Duffield, David M Hughes. Clin Rheumatol 2019
3
33

Uniphasic Blanching of the Fingers, Abnormal Capillaroscopy in Nonsymptomatic Digits, and Autoantibodies: Expanding Options to Increase the Level of Suspicion of Connective Tissue Diseases beyond the Classification of Raynaud's Phenomenon.
Francesca Ingegnoli, Roberta Gualtierotti, Annalisa Orenti, Tommaso Schioppo, Giovanni Marfia, Rolando Campanella, Claudio Mastaglio, Pier Luigi Meroni, Patrizia Boracchi. J Immunol Res 2015
10
20

Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based study.
Tracy Frech, Dinesh Khanna, Boaz Markewitz, Geraldine Mineau, Richard Pimentel, Allen Sawitzke. Arthritis Rheum 2010
31
20

Raynaud's phenomenon: a proposal for classification.
E C LeRoy, T A Medsger. Clin Exp Rheumatol 1992
236
20

Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus.
M Nakano, Y Ohuchi, H Hasegawa, T Kuroda, S Ito, F Gejyo. J Rheumatol 2000
29
20

Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity.
Frederick Wolfe, Michelle Petri, Graciela S Alarcón, John Goldman, Eliza F Chakravarty, Robert S Katz, Elizabeth W Karlson. J Rheumatol 2009
54
20

Diagnosis and risk stratification in patients with anti-RNP autoimmunity.
M F Carpintero, L Martinez, I Fernandez, A C Garza Romero, C Mejia, Y J Zang, R W Hoffman, E L Greidinger. Lupus 2015
18
20


Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison.
H R Maricq, P H Carpentier, M C Weinrich, J E Keil, Y Palesch, C Biro, M Vionnet-Fuasset, M Jiguet, I Valter. J Rheumatol 1997
101
20


Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis.
David F Fiorentino, Karen Kuo, Lorinda Chung, Lisa Zaba, Shufeng Li, Livia Casciola-Rosen. J Am Acad Dermatol 2015
89
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.